Research led by the Chiba Cancer Center Research Institute in Japan has discovered a surprising way cancer evades the immune system. It essentially hacks the immune cells, transferring its own faulty mitochondrial DNA (mtDNA) ...
A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin following standard adjuvant therapy for high-risk Dukes' B and C colorectal cancer did not yield a significant ...
Researchers from the Cancer Epidemiology Unit at the University of Oxford, along with collaborators from international institutions, found significant associations between diet and colorectal cancer risk. Examining data from ...
An observational, multicenter, real-world study conducted at 12 screening sites in Germany has reported a 17.6% higher cancer detection rate among women aged 50–69 who received AI-supported double-reading mammography screenings ...
Researchers at Dana-Farber Cancer Institute collaborated with multiple institutions to pinpoint rare germline structural variants as risk factors for non-blood-related cancers in children, including tumors in various organs. ...
An investigational therapy is demonstrating preclinical promise against non-Hodgkin lymphoma by boosting natural killer cells and efficiently annihilating the malignancy without toxicity to the patient, a team of cancer biologists ...
A multi-institutional clinical trial led by the University of Navarra, Spain, found that blocking growth differentiation factor 15 (GDF-15) can counteract resistance to anti-PD-1 and anti-PD-L1 therapies in solid tumors.
Research led by Christian Medical College in Vellore, India, has demonstrated the successful use of lentiviral vectors to deliver gene therapy for patients with severe hemophilia A. The study presents a potential alternative ...
In 1982, two Australian physician-scientists discovered a spiral-shaped bacterium whose form not only dictated function, but its capacity to dwell in the human body's harshest chemical environment. These two clues would help ...
The Netherlands Cancer Institute has found that the estrous cycle stage significantly influences mammary tumors' sensitivity to chemotherapy. In mouse models of breast cancer, treatment initiated during the diestrus stage ...
